. Overview We are a biopharmaceutical company focusing on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as active pharmaceutical ingredient, or API products. We currently manufacture and sell over 25 prescription pharmaceutical products, and an over-the-counter product, Primatene MIST . Our largest products by net revenues currently include BAQSIMI glucagon nasal powder, or BAQSIMI , Primate...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001297184-26-000009 | EDGAR | 102K words |
| 2025-03-03 | 2024-12-31 | 0001297184-25-000008 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001297184-24-000009 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0001297184-23-000019 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0001297184-22-000007 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001297184-21-000008 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001297184-20-000007 | EDGAR | — |
| 2019-03-15 | 2018-12-31 | 0001297184-19-000013 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001297184-18-000011 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001297184-17-000007 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001297184-26-000047 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001297184-25-000064 | EDGAR | 33K words |
| 2025-08-07 | 2025-06-30 | 0001297184-25-000050 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001297184-25-000029 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001297184-24-000058 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001297184-24-000048 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001297184-24-000037 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001297184-23-000082 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001297184-23-000066 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001297184-23-000049 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001297184-22-000056 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001297184-22-000044 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001297184-26-000045 | EDGAR | — |
| 2026-07-13 | 0001104659-26-082772 | EDGAR | — |
| 2026-03-16 | 0001104659-26-027814 | EDGAR | 1K words |
| 2026-03-06 | 0001297184-26-000015 | EDGAR | — |
| 2026-03-06 | 0001297184-26-000013 | EDGAR | — |
| 2026-02-26 | 0001297184-26-000007 | EDGAR | — |
| 2026-01-12 | 0001297184-26-000002 | EDGAR | — |
| 2025-11-06 | 0001297184-25-000062 | EDGAR | — |
| 2025-10-24 | 0001297184-25-000058 | EDGAR | — |
| 2025-09-18 | 0001297184-25-000054 | EDGAR | — |
176 total filings indexed. 144 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001297184 |
| Ticker | AMPH |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.amphastar.com |
| Listed | 2014-06-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AMPH (~200 tokens, structured JSON with cryptographic provenance)